About 300 reports

## Country share estimation TABLE ## List of NIH funding programs, 2013 TABLE ## Potential biomarkers and their potential applications in treating SLE TABLE ## ITP prevalence, by condition TABLE ## North America autoimmune disease diagnostics market, by type, 2013 - 2025 (USD M

  • Autoimmune Disease
  • Diagnostics
  • Pathology
  • United States
  • Market Size

Lab Test IVD for Autoimmune Disease Diagnostics Market- SWOT Analysis, by Factor ##. ## Industry Analysis - Porter’s ##. ## Technology Trends ##. ## Competitive Analysis/ Heat Map Analysis 2015 Chapter ## Market Categorization ##: Application Estimates & Trend Analysis ##. ## U.

  • Autoimmune Disease
  • Diagnostics
  • United States
  • Forecast
  • Market Size
  • 06.1 UNDERSTANDING AUTOIMMUNE DISEASES
  • Autoimmune Diseases Drugs Market in the US

About Autoimmune Diseases Autoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents. These autoantibodies cause inflammation,...

  • Autoimmune Disease
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.

Analysis of the US Autoimmune Disease Diagnostics Market ## ANALYSIS OF THE US AUTOIMMUNE DISEASE DIAGNOSTICS MARKET Executive Summary ## Scope and Segmentation ## Key Predictions: US Autoimmune Disease Diagnostics Market ## Curr

  • Autoimmune Disease
  • Diagnostics
  • United States
  • Forecast
  • Market Size
  • Identifying Factors Impacting Market Growth
  • ABBVIE

MS is an autoimmune disease that affects the brain and the spinal cord.

  • Autoimmune Disease
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Johnson & Johnson
  • PROTEOMICS APPROACH: AUTOIMMUNE DISEASE BIOMARKER DISCOVERY
  • AUTOIMMUNE DISORDERS

The biomarker technologies market is projected to grow at a CAGR of 9.7%. The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period The growth of this market is mainly driven by increasing healthcare expenditure and...

  • Autoimmune Disease
  • United States
  • Market Size
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Identifying factors that impede market growth
  • Market challenges

About Anti-Nuclear Antibody (ANA) Testing Antibodies that attack healthy proteins in the nucleus cells are called antinuclear antibodies. When a person has an autoimmune disease such as rheumatoid arthritis or systemic lupus erythematosus (SLE), the immune system produces antibodies that will attach to the cells, often causing...

  • Autoimmune Disease
  • United States
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Thermo Fisher Scientific, Inc.
  • KEY TAKEAWAYS
  • IMPACT OF DRIVERS AND CHALLENGES

About Immunohematology Blood loss or anemia can lead to chronic health problems; therefore, clinicians performs blood transfusion that can help to get relief from chronic health problems. To transfuse, blood clinicians or hospitals take blood units present in their own integrated blood banks or from other centers. Immunohematology,...

  • Autoimmune Disease
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.

Autoimmune diseases include a broad spectrum of diseases that can affect any body part.

  • Autoimmune Disease
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • INCREASE IN PUBLIC AWARENESS PROGRAMS
  • Identifying factors impacting market growth

About Vasculitis Treatment Vasculitis is an autoimmune disorder that causes inflammation of the blood vessels. The body’s immune system attacks the blood vessels, which results in inflammation. When this inflammation occurs, the walls of the affected blood vessels get thicker and the passages through which the blood flows get...

  • Autoimmune Disease
  • United States
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.

The diagnosed prevalent cases are further segmented by severity (mild to moderate, moderate to severe, and severe to fulminant) and by comorbid autoimmune diseases (psoriasis, ankylosing spondylitis, and pyodermagangrenosum).

  • Autoimmune Disease
  • Digestive System Disorder
  • Pathology
  • United States
  • World
  • IMPACT OF DRIVERS AND CHALLENGES
  • KEY TAKEAWAYS

About Immunotherapy Drugs Immunotherapy enhances the innate powers of the immune system. The properties of the immune system to fight abnormal cells give immunotherapy drugs the chance of successfully fighting diseases such as cancer, respiratory, infectious, and autoimmune disorders. Technavio’s analysts forecast the global...

  • Autoimmune Disease
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.

Abstract Psoriasis (PsO) is a chronic autoimmune disease that results from the overproduction of skin cells that causes redness and inflammation.

  • Anti Rheumatic
  • Autoimmune Disease
  • Pathology
  • Therapy
  • United States

Therefore, the market is segmented by diseases.

  • Anti Rheumatic
  • Autoimmune Disease
  • Pathology
  • Therapy
  • United States

Both diseases affect the GI system with similar symptoms while the course of the diseases and treatments may be different.

  • Anti Rheumatic
  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Ankylosing Spondylitis Market by Segment, U. S., ##

  • Anti Rheumatic
  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States

UC IS KNOWN TO BE ASSOCIATED WITH AUTOIMMUNE DISEASES, INCLUDING AUTOIMMUNE HEPATITIS AND AUTOIMMUNE PANCREATITIS.

  • Autoimmune Disease
  • Spain
  • United States
  • Pfizer Inc.
  • Remicade group
  • US: AUTOIMMUNE DISEASE PREVALENCE, 2016
  • NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT

The autoimmune disease diagnosis market projected to grow at a CAGR of 8.9% during the forecast period. The global autoimmune disease diagnosis market is expected to reach USD 4.73 billion by 2022 from USD 3.09 billion in 2017, at a CAGR of 8.9%. Factors driving the growth of this market include the rising incidence of...

  • Autoimmune Disease
  • North America
  • United States
  • Forecast
  • Thermo Fisher Scientific, Inc.
  • II. US EPIDEMIOLOGY OF PSORIASIS
  • US PREVALENCE OF PSORIASIS; 2017-2026

GLOBAL EPIDEMIOLOGY OF PSORIASIS PSORIASIS IS ONE OF THE MOST PREVALENT AUTOIMMUNE DISEASE IN THE ACROSS THE GLOBE.

  • Autoimmune Disease
  • United States
  • World
  • Amgen Inc.
  • Sandoz Inc.
  • Systemic Autoimmune Disease
  • 6.1.1 GROWING PUBLIC AWARENESS OF AUTOIMMUNE DISEASE

Autoimmune Disease Diagnostics Market The global autoimmune disease diagnostics market is expected to reach USD XXmillion by 2022 from USD XXmillion in 2016. During this period, the CAGR is expected to reach around XX%. There is an increasing prevalence of autoimmune disorders such as type 1 diabetes in newborn babies coupled with...

  • Autoimmune Disease
  • Immunochemistry Test
  • United States
  • Market Size
  • Thermo Fisher Scientific, Inc.

Global Psoriasis Market DataPack - Focus on Plaque Psoriasis (2016-2020) Current Treatment Options for Psoriasis Global Psoriasis Market by Value (2013-2017E) Global Psoriasis Market by Therapy (2015) Global Psoriasis Market by Therapy (2025E) The US Autoimmune Disease Market by Va

  • Autoimmune Disease
  • Pathology
  • United States
  • World
  • Company Financials

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Crohn’s Disease Market by Segment, U. S.,

  • Anti Rheumatic
  • Autoimmune Disease
  • Pathology
  • Therapy
  • United States

Therefore, the market is segmented by diseases.

  • Anti Rheumatic
  • Autoimmune Disease
  • Therapy
  • United States
  • Market Size
  • YOY REVENUE COMPARISON OF TOP DRUGS FOR ULCERATIVE COLITIS 2011-2014 ($ MILLIONS)
  • PRODUCT SEGMENTATION BY REVENUE 2014

About Ulcerative Colitis Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum. Inflammation and ulcers are formed in the innermost lining of the colon and rectum, resulting in the production of pus and mucous. Based on the extent of inflammation and the location, ulcerative colitis can be...

  • Autoimmune Disease
  • United States
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Merck & Co., Inc.
  • UCB: KEY TAKEAWAYS
  • EPIDEMIOLOGY

Psoriatic arthritis is among the most prevalent autoimmune diseases in the US.

  • Autoimmune Disease
  • United States
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • 7.2 INCREASED AWARENESS AMONG DERMATOLOGISTS AND PRIMARY CARE

Janus kinase inhibitors in autoimmune diseases.

  • Autoimmune Disease
  • United States
  • Amgen Inc.
  • Pfizer Inc.
  • Remicade group

IT WORKS FOR DEVELOPMENT OF CROHN' S DISEASE, IMMUNO-ONCOLOGY AND AUTOIMMUNE DISEASES.

  • Autoimmune Disease
  • United States
  • DuPont
  • Enterome Bioscience SA
  • Synlogic, Inc.
  • PRESENTS AN ASSESSMENT OF ELI LILLY'S PSORIASIS PORTFOLIO.
  • ELI LILLY'S PSORIASIS PORTFOLIO ASSESSMENT, 2015

JAKINIBS: A NEW CLASS OF KINASE INHIBITORS IN CANCER AND AUTOIMMUNE DISEASE.

  • Autoimmune Disease
  • United States
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • 4.5.3 Sex-Specific Diagnosed Prevalent Cases of Primary SS
  • 4.1 DISEASE BACKGROUND

Opportunity Analyzer: Sjögren’s Syndrome - Opportunity Analysis and Forecast to 2024 Summary Sjögren’s syndrome (SS) is a slow progressing chronic autoimmune disease, which predominantly affects middle-aged women, and is characterized by lymphocytic infiltration of the exocrine glands, mainly the lacrimal and salivary...

  • Autoimmune Disease
  • United States
  • Allergan plc
  • GlobalData's company
  • Novartis AG
  • 6A) RORGAMMA ANTAGONISTS FOR INFLAMMATORY AND AUTOIMMUNE DISEASES
  • TAKEDA PHARMACEUTICAL CO.

RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma antagonists and agonists Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but „difficult-to-drug“ target. More than 30 companies are active in drug discovery and development. Technology companies...

  • Autoimmune Disease
  • United States
  • 4SC Discovery GmbH
  • Advinus
  • AstraZeneca PLC